Svas Biosana S.p.A. lists on Euronext Growth Milan

Dec 09 2021 - 12:30

  • 35th listing of 2021 on Euronext Growth Milan
  • Svas Biosana S.p.A. brings the total number of companies listed on Euronext Growth Milan to 166
  • Total placement volume of the offering equal to €23 million

Borsa Italiana, part of the Euronext Group, today congratulates Svas Biosana S.p.A. on its listing on Euronext Growth Milan.

Svas Biosana S.p.A. Svas Biosana produces and distributes medical devices in Italy and abroad.

Svas Biosana S.p.A. represents the 35th listing since the beginning of the year on Borsa Italiana’s market dedicated to small and medium sized companies, and it brings the total number of firms currently listed on Euronext Growth Milan to 166.

In the placement phase, Svas Biosana S.p.A. raised €20 million excluding the potential exercise of an over-allotment option. In the case of the full exercise of the over-allotment option, the total amount raised will be €23 million. The free float at the time of admission was 28.57% and the market capitalisation at IPO was €70 million.

Umberto Perillo, CEO of Svas Biosana, said: "We are very proud of the listing on Euronext Growth Milan, and thanks to the listing we will be able to further consolidate our position on the markets. We believe that the geographical expansion of the Group and the strengthening of our production lines will be the pillars of our future path. A special thanks to those who have trusted us, first and foremost the investors, to those who have accompanied us during this exciting journey and to all our employees and collaborators for their valuable professional contribution."

Download PDF here

The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.